Close this search box.

A national data supplier reviewed PCSK9 inhibitor claims for managed care organizations in South Carolina from January 2017 through December 2017.

Of national health plans that received at least 50 claims for PCSK9 inhibitors, the following had the highest rates of rejection:

Read the report card


Leave a Reply

Your email address will not be published. Required fields are marked *